Aurobino gets approval for Vicoprofen generic
DAYTON, N.J. — Aurobindo Pharma Ltd. has been cleared by the Food and Drug Administration to market hydrocodone bitartrate and ibuprofen tablets 7.5 mg/200 mg (C-II), a combination opioid and nonsteroidal anti-inflammatory drug (NSAID) painkiller. Aurobindo said its combination hydrocodone/ibuprofen product is a generic version of Vicoprofen tablets from AbbVie Inc. Hydrocodone bitartrate and ibuprofen
